Martin A - Search Results

1

Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.

Martin A, Escriou N, Chao SF, Girard M, Lemon SM, Wychowski C. Martin A, et al. Virology. 1995 Oct 20;213(1):213-22. doi: 10.1006/viro.1995.1561. Virology. 1995. PMID: 7483265 Free article.

2

Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera.

Yeates TO, Jacobson DH, Martin A, Wychowski C, Girard M, Filman DJ, Hogle JM. Yeates TO, et al. Among authors: martin a. EMBO J. 1991 Sep;10(9):2331-41. doi: 10.1002/j.1460-2075.1991.tb07772.x. EMBO J. 1991. PMID: 1651227 Free PMC article.

3

Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.

Couderc T, Martin A, Wychowski C, Girard M, Horaud F, Crainic R. Couderc T, et al. Among authors: martin a. J Gen Virol. 1991 Apr;72 ( Pt 4):973-7. doi: 10.1099/0022-1317-72-4-973. J Gen Virol. 1991. PMID: 1707949

4

Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model.

Martin A, Benichou D, Couderc T, Hogle JM, Wychowski C, Van der Werf S, Girard M. Martin A, et al. Virology. 1991 Feb;180(2):648-58. doi: 10.1016/0042-6822(91)90078-p. Virology. 1991. PMID: 1846492

5

Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.

Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M. Martin A, et al. EMBO J. 1988 Sep;7(9):2839-47. doi: 10.1002/j.1460-2075.1988.tb03140.x. EMBO J. 1988. PMID: 2460345 Free PMC article.

6

An insight into poliovirus biology.

Crainic R, Couderc T, Martin A, Wychowski C, Girard M, Horaud F. Crainic R, et al. Among authors: martin a. Adv Exp Med Biol. 1989;257:61-6. doi: 10.1007/978-1-4684-5712-4_8. Adv Exp Med Biol. 1989. PMID: 2482671 Review. No abstract available.

7

Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.

Martin A, Wychowski C, Benichou D, Crainic R, Girard M. Martin A, et al. Ann Inst Pasteur Virol. 1988 Jan-Mar;139(1):79-88. doi: 10.1016/s0769-2617(88)80008-x. Ann Inst Pasteur Virol. 1988. PMID: 2849960

8

The use of picornaviruses as vectors for the engineering of live recombinant vaccines.

Girard M, Altmeyer R, van der Werf S, Wychowski C, Martin A. Girard M, et al. Among authors: martin a. Biologicals. 1995 Jun;23(2):165-9. doi: 10.1006/biol.1995.0027. Biologicals. 1995. PMID: 7546659 Review. No abstract available.

9

Potential use of poliovirus as a vector.

Girard M, Martin A, van der Werf S. Girard M, et al. Among authors: martin a. Biologicals. 1993 Dec;21(4):371-7. doi: 10.1006/biol.1993.1098. Biologicals. 1993. PMID: 8024753 Review.

10

A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F. Tardy-Panit M, et al. Among authors: martin a. J Virol. 1993 Aug;67(8):4630-8. doi: 10.1128/JVI.67.8.4630-4638.1993. J Virol. 1993. PMID: 8392604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,084 results

Search Page

Filters